Topics

Onyx Pharmaceuticals Company Profile

06:24 EST 10th December 2019 | BioPortfolio

Onyx Pharmaceuticals, Inc. is engaged in the discovery and development of novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company's strategy is to capitalize on the discoveries that have established cancer as a genetic disease. When certain genes are mutated, cells grow and proliferate unchecked and become resistant to internal mechanisms that would normally cause their death. The Company's drug discovery and development programs focus on innovative therapies that target the most frequent mutations causing cancer.

Location

2100 Powell Street
Emeryville
CA
94608
United States of America

Contact

Phone: 510.597.6500
Fax: 510.597.6600


News Articles [561 Associated News Articles listed on BioPortfolio]

‘Removing the need for other partners’: Onyx invests in commercial API license

Onyx invests in a commercial API license and expands its UK facility to bolster its manufacturing capabilities for niche, small-scale production.

Inscripta introduces benchtop digital genome engineering platform Onyx

Gene-editing technology provider Inscripta has launched the Onyx Digital Genome Engineering platform, a fully automated benchtop instrument for genome-scale engineering. In addition, the Genome Engine...

Resolute Onyx as Good as BioFreedom in High-Bleeding-Risk Patients

The device was safe and effective in complex high-bleeding-risk patients receiving 1-month DAPT in the Onyx ONE trial, but whether that duration is optimal remains unclear. Medscape Medical News

How Inscripta’s Onyx platform is making creativity the biologist’s only limiting factor

One of the most powerful capabilities brought to the life sciences in recent decades is the ability to mutate genes to interrogate their precise role in certain processes, whether that be pathogenesis...

As New CEO of Cerevel, Coles Moves From One Neuro Startup to Another

Tony Coles, the biotech veteran who once steered Onyx Pharmaceuticals into a $10 billion buyout, has left one neurology startup to join another. Coles on Monday was named the CEO of Cerevel Therapeuti...

Amgen’s Galimi Jumps to Adicet Bio to Become Chief Medical Officer

Francesco Galimi has been appointed senior vice president and chief medical officer of Adicet Bio. Galimi comes to the Menlo Park, CA-based cancer drug developer from Amgen (NASDAQ: AMGN), where he wa...

Yumanity’s Coles picks Merrimack, Onyx alum Peters to lead company to the clinic

Onyx Scientific eyes UK facility expansion for commercial API licence

Licence approval from the MHRA is expected this year and will see the British CRO take customers’ projects from concept to market

Drugs and Medications [0 Results]

None

PubMed Articles [136 Associated PubMed Articles listed on BioPortfolio]

Pre-surgical embolization of intracranial meningioma with Onyx: A safety and efficacy study.

Pre-surgical embolization of large intracranial meningioma has been demonstrated to decrease blood loss and to improve the resectability of the tumor. Few reports have evaluated the risk and benefits ...

Outcomes After Onyx Embolization as Primary Treatment for Cranial Dural Arteriovenous Fistula in the Past Decade.

This retrospective single-center study aims to evaluate endovascular therapy (EVT) of cranial dural arteriovenous fistulas (dAVF) with ethylene vinyl alcohol (EVOH) copolymer (Onyx) regarding occlusio...

Mytilidae as model organisms in the marine ecotoxicology of pharmaceuticals - A review.

Growing production and consumption of pharmaceuticals is a global problem. Due to insufficient data on the concentration and distribution of pharmaceuticals in the marine environment, there are no app...

Occurrence and ranking of pharmaceuticals in the major rivers of China.

Residual pharmaceuticals have received widespread attention worldwide due to their continuous release and potential hazard to the environment. As a result of rapid development and a large population, ...

Analysis, occurrence and removal of pharmaceuticals in African water resources: A current status.

Pharmaceuticals are organic compounds used in medicines for alleviation of pain. Since 2017, there has been a steady increase on the availability of information on contamination of water resources cau...

Clinical Trials [268 Associated Clinical Trials listed on BioPortfolio]

IRIS-Onyx Cohort in the IRIS-DES Registry

The purpose of this study is to evaluate the relative effectiveness and safety of Onyx stent compared to other (drug eluting stents) DES.

Effect and Efficacy of Onyx™, Zotarolimus-eluting Stent for Coronary Atherosclerosis

The objectives of this study are 1. To establish a prospective registry of the whole patients who received percutaneous coronary intervention with Resolute Onyx™ stent. ...

ONYX-015 With Cisplatin and Fluorouracil in Treating Patients With Advanced Head and Neck Cancer

RATIONALE: A specially modified virus called ONYX-015 may be able to kill tumor cells while leaving normal cells undamaged. Drugs used in chemotherapy use different ways to stop tumor cell...

Study Comparing Onyx and TRUFILL in Brain Arteriovenous Malformations (AVMs)

Test whether AVMs treated with Onyx is equivalent to treatment with n-BCA. Success is defined as an AVM size reduction greater than 50%

RESOLUTE ONYX China Single Arm Study

It is a single arm clinical evaluation of safety and efficacy of the Medtronic Resolute Onyx™ zotarolimus-eluting coronary stent system in subjects who are eligible for percutaneous tran...

Companies [1403 Associated Companies listed on BioPortfolio]

Onyx Pharmaceuticals, Inc.

Onyx Pharmaceuticals, Inc. is a biopharmaceutical company committed to improving the lives of people with cancer. The company, in collaboration with Bayer HealthCare Pharmaceuticals, Inc., is developi...

Onyx Pharmaceuticals

Onyx Pharmaceuticals, Inc. is engaged in the discovery and development of novel therapeutics based upon the genetics of human disease, with an emphasis on cancer. The Company's strategy is to capitali...

Bayer HealthCare Pharmaceuticals, Inc. and Onyx Pharmaceuticals, Inc.

Contact: FOR MORE INFORMATION, PLEASE CALL: MultiVu Media Relations, 1-800-653-5313 EXT. 3

Onyx Scientific Limited

Onyx Scientific is one of the fastest growing pharmaceutical service companies in the UK. We have more than 40 expert scientists specialising in drug development from medicinal chemistry to early stag...

Onyx Environmental Services

Onyx Environmental Services is the leading provider of environmental services in the United States. Our network of service centers, treatment, recovery and disposal facilities, sales offices and trans...

More Information about "Onyx Pharmaceuticals" on BioPortfolio

We have published hundreds of Onyx Pharmaceuticals news stories on BioPortfolio along with dozens of Onyx Pharmaceuticals Clinical Trials and PubMed Articles about Onyx Pharmaceuticals for you to read. In addition to the medical data, news and clinical trials, BioPortfolio also has a large collection of Onyx Pharmaceuticals Companies in our database. You can also find out about relevant Onyx Pharmaceuticals Drugs and Medications on this site too.

Quick Search

Relevant Topics

Drug Discovery
Clinical Approvals Clinical Trials Drug Approvals Drug Delivery Drug Discovery Generics Drugs Prescription Drugs In the fields of medicine, biotechnology and pharmacology, drug discovery is the process by which drugs are dis...

Cancer
  Bladder Cancer Brain Cancer Breast Cancer Cancer Cervical Cancer Colorectal Head & Neck Cancers Hodgkin Lymphoma Leukemia Lung Cancer Melanoma Myeloma Ovarian Cancer Pancreatic Cancer ...

Head and neck cancers
Cancer can occur in any of the tissues or organs in the head and neck. There are over 30 different places that cancer can develop in the head and neck area. Mouth cancers (oral cancers)  - Mouth cancer can develop on the lip, the tongue, the floor...


Corporate Database Quicklinks



Searches Linking to this Company Record